NCT00185315View on ClinicalTrials.gov

Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

71

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

August 31, 2005

Conditions

Hypertension, Pulmonary

Interventions

DRUG

Ventavis (Iloprost, BAYQ6256)

Inhaled iloprost

Trial Locations (16)

1070

Brussels

3000

Leuven

27040

Montescano

28041

Madrid

37044

Tours

38043

Grenoble

40138

Bologna

51092

Reims

56100

Pisa

59037

Lille

92141

Clamart

1081 HV

Amsterdam

01138

Warsaw

3000-076

Coimbra

4434-506

Vila Nova de Gaia

08035

Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY